EPO and anemia: Long-term use of tacrolimus, cyclosporine A [20], ACEI, ARB [21] in MN patients with persistent unalleviated urinary protein would also lead to chronic fibrosis of renal tubules and the interstitium or EPO resistance and would eventually make anemia in these MN patients difficult to treat.